Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,610.00
+60.00 (0.92%)
At close: May 8, 2026
Market Cap91.23B -3.6%
Revenue (ttm)202.40B +0.1%
Net Income15.26B -1.4%
EPSn/a
Shares Out14.04M
PE Ratio5.98
Forward PEn/a
Dividend100.00 (1.51%)
Ex-Dividend DateDec 29, 2025
Volume61,089
Average Volume90,390
Open6,560.00
Previous Close6,550.00
Day's Range6,540.00 - 6,670.00
52-Week Range6,300.00 - 8,810.00
Beta0.25
RSI32.01
Earnings DateDec 2, 2025

About Daehan Nupharm

Daehan Nupharm Co.,Ltd. manufactures and sells pharmaceuticals and veterinary products in South Korea and internationally. It offers pharmaceuticals drugs for cardiovascular, endocrine system, neuropsychiatric, gastrointestinal, respiratory system, antipyretic, analgesic, anti-inflammatory, anti-infective, musculoskeletal, osteoporosis, anti-cancer, urogenital system, antifungal, antiviral, hormones, dermatologic, central nervous system, anticonvulsive, amino acid, anesthetic, antiobesity, and others; vitamins; and inorganic products. The compa... [Read more]

Industry Pharmaceutical Preparations
Founded 1984
Employees 228
Stock Exchange KOSDAQ
Ticker Symbol 054670
Full Company Profile

Financial Performance

In 2025, Daehan Nupharm's revenue was 202.40 billion, an increase of 0.11% compared to the previous year's 202.19 billion. Earnings were 15.26 billion, a decrease of -1.36%.

Financial Statements